BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
Influenza
,
Neuron
,
Anticancer prodrugs
,
Lipitor
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Bortezomib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
HSPA1A
HSPA6
HSPA1B
MAFF
PSMD1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
PUJANA_CHEK2_PCC_NETWORK
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Proteosome inhibitor bortezomib and ERAD inhibitor eeyarestatin I treated JEKO-1 cells
Spleen from PBS or bortezomib pretreated mice exposed to Staphylococcal Enterotoxin B
Caspase-independent necrotic death activated in apoptosis-resistant glioblastoma cells
Mantle cell lymphoma cell lines with induced bortezomib resistance
Ewing's sarcoma cells treated with 20S proteasome inhibitors and novel benzyl-4-piperidone analogs
Explore Curated Studies Results
Literature
Most Relevant Literature
Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by…
Lysosomal dysfunction in Schwann cells is involved in bortezomib-induced peripheral neurotoxicity.
Alternating bortezomib-dexamethasone and lenalidomide-dexamethasone in patients with newly diagnosed…
Calcium silicate/bortezomib combinatory therapy for multiple myeloma.
Pneumonitis associated with bortezomib in a patient with multiple myeloma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bortezomib Consolidation Trial
Treatment of Adult-Onset Immunodeficiency With Bortezomib
Desensitization With Bortezomib Before a Living Kidney Donation
Bortezomib in Rejection of Kidney Transplants
Bortezomib for Treating Glomerular Diseases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ